Vancomycin-dependent Enterococcus faecium vanA: Characterization of the first case isolated in a university hospital in Brazil

Brazilian Journal of Medical and Biological Research

Volumn 44, Issue 3, 2011, Pages 253-257

  Kerbauy, G ^a   Perugini, M R E ^a   Yamauchi, L M ^a   Yamada Ogatta, S F ^a  

^a STATE UNIVERSITY OF LONDRINA   (Brazil)

Author keywords

Dependence; Enterococcus faecium; vanA genotype; Vancomycin; Virulence factors

Indexed keywords

AMPICILLIN; CHLORAMPHENICOL; CIPROFLOXACIN; ERYTHROMYCIN; LEVOFLOXACIN; MEROPENEM; NUCLEOTIDE; PENICILLIN G; RIFAMPICIN; TEICOPLANIN; VANCOMYCIN;

AGAR DIFFUSION; AGED; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM ISOLATION; CASE REPORT; DRUG WITHDRAWAL; ENTEROCOCCUS FAECIUM; EPSILOMETER TEST; FEMALE; FRAMESHIFT MUTATION; GENE SEQUENCE; HUMAN; MENINGITIS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; PENICILLIN RESISTANCE; POLYMERASE CHAIN REACTION; POSTOPERATIVE COMPLICATION; POSTOPERATIVE INFECTION; STOP CODON; VANCOMYCIN DEPENDENT ENTEROCOCCUS FAECIUM; VANCOMYCIN RESISTANT ENTEROCOCCUS;

BACTERIA (MICROORGANISMS); ENTEROCOCCUS FAECIUM; STAPHYLOCOCCUS AUREUS;

EID: 84855448766     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X2011007500006     Document Type: Article

References (19)

1. Gales AC, Sader HS, Ribeiro J, Zoccoli C, Barth A, Pignatari AC. Antimicrobial susceptibility of Gram-positive bacteria isolated in Brazilian hospitals participating in the SENTRY Program (2005-2008). Braz J Infect Dis 2009; 13: 90-98.
2. Panesso D, Reyes J, Rincon S, Diaz L, Galloway-Pena J, Zurita J, et al. Molecular epidemiology of vancomycinresistant Enterococcus faecium: a prospective, multicenter study in South American hospitals. J Clin Microbiol 2010; 48: 1562-1569.
3. Fraimow HS, Jungkind DL, Lander DW, Delso DR, Dean JL. Urinary tract infection with an Enterococcus faecalis isolate that requires vancomycin for growth. Ann Intern Med 1994; 121: 22-26.
4. Bert F, Leflon-Guibout V, Le Grand J, Bourdon N, Nicolas-Chanoine MH. [Emergence of vancomycin-dependent enterococci following glycopeptide therapy: case report and review]. Pathol Biol 2009; 57: 56-60.
5. CLSI - Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing. Approved standard M100-S20-U. Wayne: CLSI; 2009.
6. Petrich AK, Luinstra KE, Groves D, Chernesky MA, Mahony JB. Direct detection of vanA and vanB genes in clinical specimens for rapid identification of vancomycin resistant enterococci (VRE) using multiplex PCR. Mol Cell Probes 1999; 13: 275-281.
7. Ruzon FI, Paula SB, Kanoshiki RL, Pereira-Santos J, Kerbauy G, Kobayashi RKT, et al. Virulence determinants in vancomycin-resistant Enterococcus faecium isolated from different sources at University Hospital of Londrina, Paraná, Brazil. J Microbiol 2010; 48: 814-821.
8. Gholizadeh Y, Prevost M, Van Bambeke F, Casadewall B, Tulkens PM, Courvalin P. Sequencing of the ddl gene and modeling of the mutated D-alanine:D-alanine ligase in glycopeptide-dependent strains of Enterococcus faecium. Protein Sci 2001; 10: 836-844.
9. Tanimoto K, Nomura T, Hamatani H, Xiao YH, Ike Y. A vancomycin-dependent VanA-type Enterococcus faecalis strain isolated in Japan from chicken imported from China. Lett Appl Microbiol 2005; 41: 157-162.
10. Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control 2008; 36: 309-332.
11. Vankerckhoven V, Huys G, Vancanneyt M, Snauwaert C, Swings J, Klare I, et al. Genotypic diversity, antimicrobial resistance, and virulence factors of human isolates and probiotic cultures constituting two intraspecific groups of Enterococcus faecium isolates. Appl Environ Microbiol 2008; 74: 4247-4255.
12. Camargo IL, Gilmore MS, Darini AL. Multilocus sequence typing and analysis of putative virulence factors in vancomycin- resistant and vancomycin-sensitive Enterococcus faecium isolates from Brazil. Clin Microbiol Infect 2006; 12: 1123-1130.
13. Singh KV, Coque TM, Weinstock GM, Murray BE. In vivo testing of an Enterococcus faecalis efaA mutant and use of efaA homologs for species identification. FEMS Immunol Med Microbiol 1998; 21: 323-331.
14. Zeng J, Teng F, Murray BE. Gelatinase is important for translocation of Enterococcus faecalis across polarized human enterocyte-like T84 cells. Infect Immun 2005; 73: 1606-1612.
15. Singh KV, Qin X, Weinstock GM, Murray BE. Generation and testing of mutants of Enterococcus faecalis in a mouse peritonitis model. J Infect Dis 1998; 178: 1416-1420.
16. Shankar N, Lockatell CV, Baghdayan AS, Drachenberg C, Gilmore MS, Johnson DE. Role of Enterococcus faecalis surface protein Esp in the pathogenesis of ascending urinary tract infection. Infect Immun 2001; 69: 4366-4372.
17. Heikens E, Bonten MJ, Willems RJ. Enterococcal surface protein Esp is important for biofilm formation of Enterococcus faecium E1162. J Bacteriol 2007; 189: 8233-8240.
18. Courvalin P. Vancomycin resistance in Gram-positive cocci. Clin Infect Dis 2006; 42 (Suppl 1): S25-S34.
19. Van Bambeke F, Chauvel M, Reynolds PE, Fraimow HS, Courvalin P. Vancomycin-dependent Enterococcus faecalis clinical isolates and revertant mutants. Antimicrob Agents Chemother 1999; 43: 41-47.